Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.20p
   
  • Change Today:
    -0.60p
  • 52 Week High: 11.80
  • 52 Week Low: 6.55
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 2,612,011
  • Market Cap: £56.00m

Deal with Barclays    Trade now with Barclays Stockbrokers

Regulatory News

TR-1: Notification of major holdings 29-Apr-2024 07:00 RNS
Director/PDMR Shareholding 22-Feb-2024 07:00 RNS
Director Share Purchase 19-Feb-2024 13:42 RNS
Board Role Change and Launch of EIP 15-Feb-2024 07:00 RNS
Further data shows POLB001 potential in cancer CRS 17-Jan-2024 07:00 RNS
RSV AI Drug Candidate Analysis Update 20-Dec-2023 07:00 RNS
POLB 001 Data Presented at ASH 11-Dec-2023 07:00 RNS
Directorate Change 30-Nov-2023 07:00 RNS
Former Amryt Pharma Leadership Team join Poolbeg 09-Nov-2023 07:00 RNS
POLB001 Data to be Presented at ASH Annual Meeting 03-Nov-2023 07:05 RNS
POLB 001 Oncology Programme Update Meeting 01-Nov-2023 07:00 RNS
Poolbeg Partners with a Nasdaq-Listed Biopharma 17-Oct-2023 07:00 RNS
Favourable Conclusion of Patent Opposition 29-Sep-2023 07:00 RNS
Immunomodulator I Patent Opposition Withdrawal 19-Sep-2023 07:00 RNS
Interim results for the six months to 30 June 2023 13-Sep-2023 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 11.20p
Change Today -0.60p
% Change -5.08 %
52 Week High 11.80
52 Week Low 6.55
Volume 2,612,011
Shares Issued 500.00m
Market Cap £56.00m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
62.35% below the market average62.35% below the market average62.35% below the market average62.35% below the market average62.35% below the market average
45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average
Price Trend
95.75% above the market average95.75% above the market average95.75% above the market average95.75% above the market average95.75% above the market average
96.43% above the sector average96.43% above the sector average96.43% above the sector average96.43% above the sector average96.43% above the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
15:06 1,000,000 @ 11.23p
16:35 31,390 @ 11.20p
16:35 140 @ 11.20p
16:35 139 @ 11.20p
16:35 1 @ 11.20p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page